Literature DB >> 24364983

Muscle glucose metabolism in chronic obstructive pulmonary disease patients.

Antonio Sancho-Muñoz1, Carlos Trampal2, Sergi Pascual3, Juana Martínez-Llorens3, Roberto Chalela1, Joaquim Gea4, Mauricio Orozco-Levi5.   

Abstract

INTRODUCTION: Muscle dysfunction is one of the most extensively studied manifestations of COPD. Metabolic changes in muscle are difficult to study in vivo, due to the lack of non-invasive techniques. Our aim was to evaluate metabolic activity simultaneously in various muscle groups in COPD patients.
METHODS: Thirty-nine COPD patients and 21 controls with normal lung function, due to undergo computed axial and positron emission tomography for staging of localized lung lesions were included. After administration of 18-fluordeoxyglucose, images of 2 respiratory muscles (costal and crural diaphragm, and rectus abdominus) and 2 peripheral muscles (brachial biceps and quadriceps) were obtained, using the standard uptake value as the glucose metabolism index.
RESULTS: Standard uptake value was higher in both portions of the diaphragm than in the other muscles of all subjects. Moreover, the crural diaphragm and rectus abdominus showed greater activity in COPD patients than in the controls (1.8±0.7 vs 1.4±0.8; and 0.78±0.2 vs 0.58±0.1; respectively, P<.05). A similar trend was observed with the quadriceps. In COPD patients, uptake in the two respiratory muscles and the quadriceps correlated directly with air trapping (r=0.388, 0.427 and 0.361, respectively, P<.05).
CONCLUSIONS: There is greater glucose uptake and metabolism in the human diaphragm compared to other muscles when the subject is at rest. Increased glucose metabolism in the respiratory muscles (with a similar trend in their quadriceps) of COPD patients is confirmed quantitatively, and is directly related to the mechanical loads confronted.
Copyright © 2013 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Cuádriceps; Diafragma; Diaphragm; Enfermedad pulmonar obstructiva crónica; Metabolism; Metabolismo; Positron emission tomography; Quadriceps; Tomografía por emisión de positrones

Mesh:

Substances:

Year:  2013        PMID: 24364983     DOI: 10.1016/j.arbres.2013.10.011

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  5 in total

1.  Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Authors:  Mahsa Eskian; Abass Alavi; MirHojjat Khorasanizadeh; Benjamin L Viglianti; Hans Jacobsson; Tara D Barwick; Alipasha Meysamie; Sun K Yi; Shingo Iwano; Bohdan Bybel; Federico Caobelli; Filippo Lococo; Joaquim Gea; Antonio Sancho-Muñoz; Jukka Schildt; Ebru Tatcı; Constantin Lapa; Georgia Keramida; Michael Peters; Raef R Boktor; Joemon John; Alexander G Pitman; Tomasz Mazurek; Nima Rezaei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-22       Impact factor: 9.236

Review 2.  Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.

Authors:  Joaquim Gea; Carme Casadevall; Sergi Pascual; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease?

Authors:  Ester Puig-Vilanova; Pilar Ausin; Juana Martinez-Llorens; Joaquim Gea; Esther Barreiro
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

Review 4.  Chemerin: A Potential Regulator of Inflammation and Metabolism for Chronic Obstructive Pulmonary Disease and Pulmonary Rehabilitation.

Authors:  Jian Li; Yufan Lu; Ning Li; Peijun Li; Zhengrong Wang; Wang Ting; Xiaodan Liu; Weibing Wu
Journal:  Biomed Res Int       Date:  2020-04-06       Impact factor: 3.411

5.  Tumor necrosis factor-like weak inducer of apoptosis regulates quadriceps muscle atrophy and fiber-type alteration in a rat model of chronic obstructive pulmonary disease.

Authors:  Jun-Juan Lu; Qing Wang; Li Hua Xie; Qiang Zhang; Sheng Hua Sun
Journal:  Tob Induc Dis       Date:  2017-11-09       Impact factor: 2.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.